Michael J. Wick
Impact in
- Oncology top 2%
- Ear and Head Tumors
- Cancer Cells and Metastasis
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 11
- Protein Kinase Regulation and GTPase Signaling 7
- Oncology 22
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 5
- Co-authors
- Lily Dong (7 shared papers)David Sidransky (4 shared papers)Manuel Hidalgo (3 shared papers)Feng Liu (4 shared papers)Elizabeth Bruckheimer (2 shared papers)Fresnida J. Ramos (3 shared papers)Amita Patnaik (5 shared papers)James Martell (1 shared paper)
- Journals
- Cancer Research (14 papers)Molecular Cancer Therapeutics (9 papers)Clinical Cancer Research (5 papers)Journal of Medicinal Chemistry (4 papers)Journal of Biological Chemistry (4 papers)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Michael J. Wick
70 papers receiving 2.6k citations
Michael J. Wick's Hit Papers
Peers
Comparison fields: 5 of 137
- Oncology 892
- Cancer Research 313
- Molecular Biology 1.3k
- Pathology and Forensic Medicine 231
- Oral Surgery 87
Countries citing papers authored by Michael J. Wick
This map shows the geographic impact of Michael J. Wick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Wick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Wick more than expected).
Fields of papers citing papers by Michael J. Wick
This network shows the impact of papers produced by Michael J. Wick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Wick. The network helps show where Michael J. Wick may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael J. Wick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer Hit paper breakdown → | 2012 | 362 |
| 2 | 2011 | 324 | |
| 3 | 2016 | 231 | |
| 4 | 2017 | 182 | |
| 5 | 2017 | 170 | |
| 6 | 2000 | 113 | |
| 7 | 2015 | 104 | |
| 8 | 2000 | 88 | |
| 9 | 2017 | 77 | |
| 10 | 2003 | 68 | |
| 11 | 2011 | 68 | |
| 12 | 2018 | 63 | |
| 13 | 2012 | 63 | |
| 14 | 2003 | 59 | |
| 15 | 2018 | 57 | |
| 16 | 2001 | 52 | |
| 17 | 1981 | 50 | |
| 18 | 2008 | 49 | |
| 19 | 2020 | 46 | |
| 20 | 2017 | 39 |
About Michael J. Wick
Michael J. Wick is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 73 papers that have together received 2.7k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (11 papers), Salivary Gland Tumors Diagnosis and Treatment (8 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Treatment and Pharmacology (5 papers), Cancer Mechanisms and Therapy (4 papers) and Cancer Research and Treatments (4 papers). The work is most often cited by research in Oncology (892 citations), Cancer Research (313 citations), Molecular Biology (1.3k citations), Pathology and Forensic Medicine (231 citations) and Oral Surgery (87 citations). Michael J. Wick has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Lily Dong, David Sidransky, Manuel Hidalgo, Feng Liu, Elizabeth Bruckheimer, Fresnida J. Ramos, Amita Patnaik, James Martell, Ignacio Garrido‐Laguna and Steven J. Strawn. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research, Journal of Medicinal Chemistry and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.